thiophenes has been researched along with thromboxane a2 in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (45.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 4 (20.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abiko, Y; Ashida, SI | 1 |
| Hashimoto, H; Hieda, N; Ito, T; Ogawa, K; Okumura, K; Satake, T; Toki, Y | 2 |
| Hieda, N; Ito, T; Ogawa, K; Ogawa, T; Ozawa, T; Satake, T; Sugiyama, S; Toki, Y | 1 |
| Verstraete, M | 1 |
| Numano, F | 1 |
| Gaillard, JL; Kher, A; Lecompte, T; Samama, M | 1 |
| Kawai, C | 1 |
| Andriani, A; Chiappetta, MG; Fabiani, M | 1 |
| Iizuka, Y; Itoh, K; Mukaiyama, O; Satoh, Y; Yamaguchi, T | 1 |
| Iizuka, Y; Itoh, K; Mukaiyama, O; Satoh, Y; Terada, A; Yamaguchi, T | 1 |
| Hisamoto, M; Ikeda, T; Itoh, K; Matsuda, K; Mukaiyama, O; Satoh, Y; Yamaguchi, T; Yamamura, N | 1 |
| Okamoto, H; Takeuchi, H; Tanabe, M; Yamazaki, M | 1 |
| Amemiya, T; Fujimura, M; Ishiura, Y; Liu, Q; Matsuda, T; Myou, S; Nobata, K; Yamamori, C | 1 |
| Fellier, H; Sadjak, A; Supanz, S | 1 |
| Schieffer, B; Schmidt, B | 1 |
| Grove, EL; Kristensen, SD | 1 |
| Aylward, PE; Behan, MW; Chew, DP | 1 |
| Barreiro, EJ; Brito, FC; Fraga, CA; Kummerle, AE; Lugnier, C; Miranda, AL | 1 |
| Boyce, JA; Laidlaw, TM | 1 |
8 review(s) available for thiophenes and thromboxane a2
| Article | Year |
|---|---|
Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
Topics: Anticoagulants; Arteriosclerosis; beta-Thromboglobulin; Blood Platelets; Clinical Trials as Topic; Humans; Intermittent Claudication; Leg; Platelet Aggregation; Platelet Factor 4; Suloctidil; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine | 1984 |
Cyclic nucleotides, prostaglandins, and ischemic heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arteriosclerosis; Coronary Disease; Diet, Atherogenic; Myocardial Contraction; Myocardial Infarction; Nucleotides, Cyclic; Prostaglandins; Rabbits; Thiophenes; Thromboxane A2; Ticlopidine | 1984 |
[Pharmacology of anti-platelet agents].
Topics: Animals; Anticoagulants; Aspirin; Blood Platelets; Cyclic AMP; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Female; Fibrinolytic Agents; Humans; In Vitro Techniques; Intestinal Absorption; Kinetics; Male; Papio; Platelet Aggregation; Prostaglandin Antagonists; Rabbits; Sulfinpyrazone; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine | 1983 |
[Platelet aggregation and antiaggregant drugs].
Topics: Dipyridamole; Humans; Papaverine; Platelet Aggregation; Prostaglandins; Theophylline; Thiophenes; Thromboxane A2; Ticlopidine; Verapamil | 1982 |
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Growth Hormone; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Models, Molecular; Receptor, Angiotensin, Type 1; Tetrazoles; Thiophenes; Thromboxane A2 | 2003 |
Update on oral antiplatelet therapy: principles, problems and promises.
Topics: Adenosine; Administration, Oral; Cardiovascular Diseases; Cilostazol; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Tetrazoles; Thiophenes; Thromboxane A2; Ticagrelor | 2009 |
The role of antiplatelet therapy in the secondary prevention of coronary artery disease.
Topics: Adenosine; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Interactions; Drug Therapy, Combination; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Factors; Secondary Prevention; Thiophenes; Thromboxane A2; Ticagrelor; Ticlopidine | 2010 |
Platelets in patients with aspirin-exacerbated respiratory disease.
Topics: Animals; Aspirin; Asthma, Aspirin-Induced; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Movement; Clinical Trials as Topic; Eosinophils; Gene Expression; Humans; Leukotrienes; Oxazoles; Piperazines; Platelet Activating Factor; Platelet Activation; Prasugrel Hydrochloride; Receptors, Leukotriene; Thiophenes; Thromboxane A2 | 2015 |
1 trial(s) available for thiophenes and thromboxane a2
| Article | Year |
|---|---|
Rationale for the use of drugs inhibiting platelet function in claudicating patients with atherosclerotic leg arteries.
Topics: Anticoagulants; Arteriosclerosis; beta-Thromboglobulin; Blood Platelets; Clinical Trials as Topic; Humans; Intermittent Claudication; Leg; Platelet Aggregation; Platelet Factor 4; Suloctidil; Thiophenes; Thrombosis; Thromboxane A2; Ticlopidine | 1984 |
12 other study(ies) available for thiophenes and thromboxane a2
| Article | Year |
|---|---|
Inhibition of platelet aggregation by a new agent, Ticlopidine.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Blood Platelets; Cell Survival; Collagen; Male; Platelet Aggregation; Prostaglandins G; Pyridines; Rats; Thiophenes; Thrombin; Thromboxane A2 | 1979 |
Protective effects of a thromboxane synthetase inhibitor, a thromboxane antagonist, a lipoxygenase inhibitor and a leukotriene C4, D4 antagonist on myocardial injury caused by acute myocardial infarction in the canine heart.
Topics: Animals; Arrhythmias, Cardiac; Benzoquinones; Cardiomyopathies; Chromones; Coronary Disease; Dogs; Hemorrhage; Lipoxygenase Inhibitors; Male; Myocardial Infarction; Myocardium; Neutrophils; Quinones; SRS-A; Thiophenes; Thromboxane A2; Thromboxane-A Synthase | 1989 |
Myocardial salvage by a novel thromboxane A2 synthetase inhibitor in a canine coronary occlusion-reperfusion model.
Topics: Animals; Arrhythmias, Cardiac; Coronary Disease; Coronary Vessels; Dogs; Hemodynamics; In Vitro Techniques; Male; Neutrophils; Risk Factors; Thiophenes; Thromboxane A2; Thromboxane-A Synthase | 1988 |
Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Female; Heart Rate; In Vitro Techniques; Lysosomes; Male; Mitochondria, Heart; Oxygen Consumption; Thiophenes; Thromboxane A2; Thromboxane-A Synthase; Time Factors | 1988 |
New horizons in cardiology.
Topics: Adult; Angina, Unstable; Anticoagulants; Coronary Disease; Coronary Vessels; Electrocardiography; Female; Humans; Male; Methacrylates; Middle Aged; Myocardial Infarction; Perfusion; Stroke Volume; Thiophenes; Thromboxane A2; Thromboxane B2; Ticlopidine; Tomography, Emission-Computed; Urokinase-Type Plasminogen Activator | 1984 |
Effects of CS-518, a thromboxane synthase inhibitor, on eosinophil function.
Topics: Animals; Asthma; Bronchoalveolar Lavage Fluid; Chemotaxis, Leukocyte; Eosinophils; Epoprostenol; Guinea Pigs; In Vitro Techniques; Male; Peroxidases; Platelet Activating Factor; Pulmonary Alveoli; Superoxides; Thiophenes; Thromboxane A2; Thromboxane-A Synthase | 1993 |
Effects of CS-518, a thromboxane synthase inhibitor, on the asthmatic response.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Asthma; Bronchial Hyperreactivity; Bronchoconstriction; Chlorpheniramine; Disease Models, Animal; Guinea Pigs; Indomethacin; Male; Methacrylates; Ovalbumin; Propranolol; Prostaglandin Endoperoxides, Synthetic; SRS-A; Thiophenes; Thromboxane A2; Thromboxane-A Synthase; Vasoconstrictor Agents | 1993 |
Alteration of eicosanoid production in the sensitized guinea pig lung by CS-518.
Topics: Administration, Oral; Animals; Arachidonic Acid; Eicosanoids; Guinea Pigs; Histamine; Indomethacin; Lung; Male; Ovalbumin; Prostaglandins; Radioimmunoassay; SRS-A; Thiophenes; Thromboxane A2; Thromboxane-A Synthase; Vaccination | 1993 |
Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm.
Topics: Animals; Basilar Artery; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoprostenol; Neuroprotective Agents; Subarachnoid Hemorrhage; Thiophenes; Thromboxane A2; Thromboxane-A Synthase; Vasospasm, Intracranial | 1999 |
Effect of thromboxane synthase inhibitor, CS-518, on propranolol-induced bronchoconstriction in guinea pigs.
Topics: Adrenergic beta-Antagonists; Animals; Bronchoconstriction; Enzyme Inhibitors; Guinea Pigs; Immunization, Passive; Male; Methacholine Chloride; Muscarinic Agonists; Propranolol; Respiration, Artificial; Thiophenes; Thromboxane A2; Thromboxane-A Synthase | 2000 |
Determination of efficacy of linotroban by inducing a reduction of renal inulin/para-aminohippuric acid clearances with the thromboxane A2 mimetic U-46619 in the conscious female rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Animals; Female; Glomerular Filtration Rate; Inulin; p-Aminohippuric Acid; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thiophenes; Thromboxane A2 | 2000 |
Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
Topics: Animals; Arachidonic Acid; Bleeding Time; Blood Platelets; Collagen; Female; Humans; Hydrazones; Male; Mice; Molecular Structure; Nucleotides, Cyclic; Phosphoric Diester Hydrolases; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Structure-Activity Relationship; Thiophenes; Thrombin; Thromboxane A2 | 2010 |